Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch ReportPRNewsWire • 01/10/22
SHAREHOLDER ALERT: Robbins LLP Investigates Clarivate Plc (CLVT) on Behalf of ShareholdersBusiness Wire • 01/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Clarivate Plc - CLVTPRNewsWire • 01/06/22
Clarivate Acquires Patient Connect, Furthering Position as a Leading Provider of Patient-Centric SolutionsPRNewsWire • 12/22/21
Clarivate and KAIST Innovation Strategy and Policy Institute Release Report on the Global AI Innovation LandscapePRNewsWire • 12/20/21
BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021PRNewsWire • 12/16/21
Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China Release Annual Joint Report to Identify 186 Engineering FrontsPRNewsWire • 12/14/21
Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 171 Research FrontsPRNewsWire • 12/08/21
New Clarivate Report Reveals Luxury Brands are Accelerating Digital Transformation to Meet Demands of Changing WorldPRNewsWire • 12/07/21
Clarivate to Present at Upcoming Investor Conferences in November and December 2021PRNewsWire • 11/24/21
Clarivate Identifies the One in 1,000 Citation Elite with Annual Highly Cited Researchers ListPRNewsWire • 11/16/21
BARDA and Clarivate Partner to Identify Therapeutics Which Can Be Repurposed as Medical Countermeasures to Chemical ExposurePRNewsWire • 11/08/21
Clarivate Plc (CLVT) CEO Jerre Stead on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21